EUVIMEDEUVIMED entdecken
Open Access

Hemoglobin scavenger receptor CD163 as a potential biomarker of hemolysis-induced hepatobiliary injury in sickle cell disease

Tomasz W Kaminski iD, Ayyanar Sivanantham, Anna Mozhenkova, Ashley Smith, Ramakrishna Ungalara, Rikesh K Dubey, Bibhav Shrestha, Corrine Hanway, Omika Katoch, Jesús Tejero iD, Prithu Sundd, Enrico M Novelli iD und 2 weitere

American Journal of Physiology-Cell Physiology · 2024

DOI: 10.1152/ajpcell.00386.2023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2024. Verfasst von Tomasz W Kaminski und 13 weiteren Autor:innen. Beteiligte Einrichtung: Thrombosis and Hemostasis Program, Versiti Blood Research Institute, Milwaukee, Wisconsin, United States. Hauptthemen laut MEDLINE: Antigens, Differentiation, Myelomonocytic, Anemia, Sickle Cell, Antigens, CD, Hemolysis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NHLBI NIH HHS, HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sickle cell disease (SCD)-associated chronic hemolysis promotes oxidative stress, inflammation, and thrombosis leading to organ damage, including liver damage. Hemoglobin scavenger receptor CD163 plays a protective role in SCD by scavenging both hemoglobin-haptoglobin complexes and cell-free hemoglobin. A limited number of studies in the past have shown a positive correlation of CD163 expression with poor disease outcomes in patients with SCD. However, the role and regulation of CD163 in SCD-related hepatobiliary injury have not been fully elucidated yet. Here we show that chronic liver injury in SCD patients is associated with elevated levels of hepatic membrane-bound CD163. Hemolysis and increase in hepatic heme, hemoglobin, and iron levels elevate CD163 expression in the SCD mouse liver. Mechanistically we show that heme oxygenase-1 (HO-1) positively regulates membrane-bound CD163 expression independent of nuclear factor erythroid 2-related factor 2 (NRF2) signaling in SCD liver. We further demonstrate that the interaction between CD163 and HO-1 is not dependent on CD163-hemoglobin binding. These findings indicate that CD163 is a potential biomarker of SCD-associated hepatobiliary injury. Understanding the role of HO-1 in membrane-bound CD163 regulation may help identify novel therapeutic targets for hemolysis-induced chronic liver injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antigens, Differentiation, MyelomonocyticAnemia, Sickle CellAntigens, CDHemolysisReceptors, Cell SurfaceBiomarkersHeme Oxygenase-1HemoglobinsAnimalsHumansMiceMaleLiverFemaleMice, Inbred C57BLAdultNF-E2-Related Factor 2HemeLiver DiseasesSignal TransductionHaptoglobinsMembrane ProteinsCD163 Antigen

Stichwörter der Autor:innen

CD163HO-1hemoglobin clearancehemolysissickle cell disease

Substanzen

CD163 AntigenAntigens, Differentiation, MyelomonocyticAntigens, CDReceptors, Cell SurfaceBiomarkersHeme Oxygenase-1HemoglobinsHMOX1 protein, humanNF-E2-Related Factor 2Hmox1 protein, mouse

Autor:innen und Institutionen

  • Thrombosis and Hemostasis Program, Versiti Blood Research Institute, Milwaukee, Wisconsin, United States.
  • Transfusion Medicine, Vascular Biology and Cell Therapy Program, Versiti Blood Research Institute, Milwaukee, Wisconsin, United States.
  • Pittsburgh Heart, Lung and Blood Vascular Medicine Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States.
  • Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, United States.
  • Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States.

ORCID-Profile: Tomasz W Kaminski, Jesús Tejero, Enrico M Novelli, Tirthadipa Pradhan-Sundd

Förderung

  • HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  • NHLBI NIH HHS
  • HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)
  • American Society of Hematology (ASH)
  • NIDDK NIH HHS
  • American Heart Association (AHA)
  • Versiti

Zitieren

APA

Kaminski, T. W., Sivanantham, A., Mozhenkova, A., Smith, A., Ungalara, R., Dubey, R. K., Shrestha, B., Hanway, C., Katoch, O., Tejero, J., Sundd, P., Novelli, E. M., Kato, G. J., & Pradhan-Sundd, T. (2024). Hemoglobin scavenger receptor CD163 as a potential biomarker of hemolysis-induced hepatobiliary injury in sickle cell disease. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00386.2023

Vancouver

Kaminski TW, Sivanantham A, Mozhenkova A, Smith A, Ungalara R, Dubey RK, et al. Hemoglobin scavenger receptor CD163 as a potential biomarker of hemolysis-induced hepatobiliary injury in sickle cell disease. American Journal of Physiology-Cell Physiology. 2024. doi:10.1152/ajpcell.00386.2023

BibTeX
@article{Kaminski2024,
  author = {Kaminski, Tomasz W and Sivanantham, Ayyanar and Mozhenkova, Anna and Smith, Ashley and Ungalara, Ramakrishna and Dubey, Rikesh K and Shrestha, Bibhav and Hanway, Corrine and Katoch, Omika and Tejero, Jesús and Sundd, Prithu and Novelli, Enrico M and Kato, Gregory J and Pradhan-Sundd, Tirthadipa},
  title = {Hemoglobin scavenger receptor CD163 as a potential biomarker of hemolysis-induced hepatobiliary injury in sickle cell disease},
  journal = {American Journal of Physiology-Cell Physiology},
  year = {2024},
  doi = {10.1152/ajpcell.00386.2023}
}
Kostenlos starten →